CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Shilpa Medicare Limited recalls PEMRYDI RTU (pemetrexed injection) and…

Shilpa Medicare Limited recalls PEMRYDI RTU (pemetrexed injection) and 1 more

Read the official FDA notice

Published
26 Aug 2026
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1

PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2461-1

Brand / company
Shilpa Medicare Limited
Codes / lots
Lot: P400172; Lot PA00050A, Exp 09/30/2027 | Lot: P400157, Exp 08/31/2026; Lot PA00047A, Exp 09/30/2027
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 26 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.